Muscle Growth (Hypertrophy) Rate

Muscle growth runs on a cascade of signals: ACVR1B (activin receptor) governs how strongly the body responds to anabolic training; MSTN (myostatin) is the brake on muscle growth (less MSTN means more growth potential); IGF1 and AKT1 sit at the protein synthesis switch downstream of training and protein intake.

Carriers of MSTN reduced-activity variants are associated with elevated muscle-growth potential. Rare extreme cases produce visibly heavier-muscled phenotypes, while more common variants shift response within the normal range. Carriers of ACVR1B and IGF1 favorable variants are associated with stronger hypertrophy response to the same training stimulus. Carriers of less-favorable combinations build muscle more slowly even on identical programs.

Resistance training with progressive overload is the primary driver. Adequate protein at 0.7–1g per pound of bodyweight, distributed across 3–4 meals daily, supports the synthesis side. Sleep is when most of the muscle building happens. Chronic under-sleeping suppresses hypertrophy regardless of training volume. Creatine supplementation provides a meaningful additional response in most carriers.

Two people on identical training programs and identical nutrition can build very different amounts of muscle. Which MSTN/ACVR1B/IGF1 pattern you carry decides whether progress matches expectations or whether the realistic ceiling sits higher or lower than the program assumes, and where the strongest lever sits.